Orbis Medicines

Orbis Medicines is a biotechnology company focused on developing oral macrocycle drugs. Their nGen platform uses high-throughput chemical synthesis and machine learning to create 'nCycles,' orally bioavailable macrocycles targeting a wide range of diseases and previously unreachable molecular targets.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: €26M

Date: 29-Feb-2024

Investors: Novo Holdings, Forbion

Markets: Biotechnology, Pharmaceuticals, Therapeutics, Health Care, Medical

HQ: Copenhagen, Denmark

Founded: 2021

Website: https://www.orbismedicines.com/

LinkedIn: https://www.linkedin.com/company/orbismedicines/

Twitter:

Instagram: